CADTH has received the following notice(s) of pending drug submission(s).
naltrexone hydrochloride and bupropion hydrochloride
Bausch Health, Canada Inc.
Chronic weight management in adults
Call for patient input
Patient input deadline
Ottawa, ON (March 28, 2019) — CADTH is pleased to celebrate outstanding and ongoing achievements in the field of health technology assessment (HTA) by announcing the recipients of the 2019 CADTH Recognition Awards.
In addition to honouring two individuals who have made significant contributions to the field of HTA in Canada, 10 Anniversary Medal...
A document related to the project entitled Non-Pharmacological Prevention of Pressure Injuries: An Environmental Scan is now available for feedback from all interested stakeholders.
Call for Feedback
Feedback Due By
Non-Pharmacological Prevention of Pressure Injuries: An Environmental Scan
CADTH is seeking nominations for its advisory and expert committees. If you have significant expertise in the Canadian health care system, are interested in helping support health care decision-makers in making informed choices about health technologies, and are passionate about ensuring that the Canadian health care system is the best it can be...
Read this month’s issue of New at CADTH. Here, you’ll find the latest information on our products and services, corporate news, and news flashes of upcoming events across Canada.